English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduFindings may help inform the development of intervention and prevention strategies
Tag: Mount Sinai Health System
Mount Sinai Participates in $40 Million Multisite Study of Alzheimer’s Disease in Asian Americans and Asian Canadians
Study represents a major milestone toward health equity for underrepresented populations in Alzheimer’s disease research
Mount Sinai Launches Center for Ophthalmic Artificial Intelligence and Human Health
The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States.
Mount Sinai Institute for Exposomics Research Awarded $8.45 Million Grant to Study Environmental Health
New five-year award will focus on the effects of environmental exposures on health across the lifespan
Mount Sinai Patients Receive Greater and Faster Access to Care With New Expanded Digital Tools
Mount Sinai Health System patients will experience greater access to care, fast identification of symptoms, efficient online search and connection to specialists, and easy appointment scheduling thanks to newly launched Digital Experience tools accessible on their smartphones or computers.
Mount Sinai Health System Launches New Season of Road to Resilience Podcast
The Mount Sinai Health System’s flagship podcast, Road to Resilience, is returning to the airwaves after a yearlong hiatus, the Health System announced today.
Patients With Specific Types of Lipids May Be at Higher Risk of Developing Blinding Eye Disease
Principal Investigator: Louis R. Pasquale, MD, FARVO, Deputy Chair for Ophthalmology Research for the Mount Sinai Health System Co-First Authors: Oana A. Zeleznik, PhD, Instructor in Medicine at Brigham and Women’s Hospital and Jae H. Kang, ScD, Assistant Professor of…
Mount Sinai Health System to Lead Discussions on Women’s Health, New Paths to Treat and Prevent Brain Disease, and Closing the Health Disparity Gap at the 2023 Aspen Ideas: Health and Aspen Ideas Festival
Mount Sinai Health System experts will lead key discussions on women’s health, new paths to treat and prevent brain disease, and closing the gap on health disparities at this year’s Aspen Ideas: Health and Aspen Ideas Festival.
Mount Sinai Experts Present Research at SLEEP 2023
Sleep medicine experts from the Mount Sinai Health System are presenting new research at SLEEP 2023, the 37th annual meeting of the Associated Professional Sleep Societies running until June 7 in Indianapolis.
Mount Sinai Researchers Identify Potential New Treatment for Those Who Act Out Their Dreams While Sleeping
Experts say medication commonly used to treat insomnia may also be a therapeutic option for the condition known as REM sleep behavior disorder
George Dangas, MD, PhD, Named President of Society for Cardiovascular Angiography & Interventions
First Mount Sinai cardiologist to hold this prestigious position
Researchers Show That a Machine Learning Model Can Improve Mortality Risk Prediction for Cardiac Surgery Patients
A machine learning-based model that enables medical institutions to predict the mortality risk for individual cardiac surgery patients has been developed by a Mount Sinai research team, providing a significant performance advantage over current population-derived models.
Coronary Bioresorbable Scaffolds Nearly as Safe and Effective as Conventional Metal Stents for Heart Disease Patients
First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic stents, which are currently the standard treatment for heart disease patients undergoing percutaneous coronary intervention (PCI).
New York’s Mount Sinai Health System Opens Concierge Medicine Practice in West Palm Beach
Mount Sinai Health System in New York is opening a personalized concierge care facility at 360 Rosemary in West Palm Beach, Florida.
Mount Sinai Health System Celebrates Its 38th Annual Crystal Party in Person After Four Years
Mount Sinai Health System celebrated its 38th annual Crystal Party on Thursday, May 4, returning to an in-person event at the Central Park Conservatory Garden after four years.
Mount Sinai Launches Institute for Regenerative Medicine
Institute, including three new centers, will lead research to foster novel discoveries and explore new treatments for a range of diseases from leukemia to Alzheimer’s disease.
Mount Sinai’s Chief Nurse Executive Appointed to the New York Academy of Medicine Board of Trustees
Beth Oliver, DNP, RN, Chief Nurse Executive and Senior Vice President, Cardiac Services, Mount Sinai Health System, has been appointed to the New York Academy of Medicine (NYAM)’s Board of Trustees.
Icahn School of Medicine at Mount Sinai Names New Chair of Microbiology
Ana Fernandez-Sesma, PhD, has been appointed Chair of the Department of Microbiology at the Icahn School of Medicine at Mount Sinai. Dr. Fernandez-Sesma will direct all educational and research functions of the Department, while cultivating an academic culture that advances insights into virology, vaccinology, immunology, and microbiology, and encourages innovative approaches to teaching and mentoring.
Mount Sinai Awarded Prestigious $1.3 Million Grant to Expand Research Training Program in Skin Biology
The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai will expand its research training program in skin biology with support from a five-year, $1.3 million T32 grant from the National Institutes of Health (NIH) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
Mount Sinai Health System Recognized by Fortune as One of “America’s Most Innovative Companies 2023”
Mount Sinai Health System has been named one of “America’s Most Innovative Companies 2023” by Fortune magazine.
Mount Sinai Launches Program to Increase Career Advancement Opportunities for Black Men
The Mount Sinai Health System has announced the Growth in Operations, Administrations, and Leadership Society (GOALS), an initiative to increase the representation of Black men at the middle and upper levels of management by creating pathways for career advancement through networking, mentorship, and advancement opportunities. This initiative furthers Mount Sinai’s continuing commitment to growing a diverse workplace and providing equitable care for patients.
Mount Sinai Experts Present New Research at 70th Annual Meeting of the Society for Reproductive Investigation
Reproductive health experts from the Mount Sinai Health System are presenting research at the 70th Annual Meeting of the Society for Reproductive Investigation (SRI) in Brisbane, Australia from March 21-25.
Mount Sinai Collaborates with The New York Public Library to Support Telehealth Access and Digital Literacy Skills
In an effort to expand equitable health care throughout New York City, the Digital and Technology Partners (DTP) department at Mount Sinai Health System is collaborating with The New York Public Library (NYPL) to support access to health services through electronic information or technologies—better known as telehealth—and digital literacy skills.
A Novel Mechanism May Be Effective in Patients With Severe Hypertriglyceridemia and Prior Episodes of Acute Pancreatitis
A novel type of therapy, known as ANGPTL3 inhibitor therapy, was effective in lowering triglycerides in certain types of patients with severe hypertriglyceridemia (sHTG) who had a prior episode(s) of acute pancreatitis. sHTG is a well-established risk factor for recurrent episodes of acute pancreatitis. These high-risk patients were the focus of a phase 2 study that was led by the Icahn School of Medicine at Mount Sinai and sponsored and funded by Regeneron.
New Scientific Evidence Emerges on How Individuals Transition From Recreational to Compulsive Use of Drugs
While substance use disorder (SUD) remains a clinically and socially devastating condition in the U.S. and worldwide, the phenomenon of how individuals transition from recreational to compulsive drug use is yet to be fully understood. Researchers at the Icahn School…
High-Dose Anticoagulation Can Reduce Intubations and Improve Survival for Hospitalized COVID-19 Patients
High-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is low-dose anticoagulation.
Transcatheter Mitral Valve Repair in Heart Failure Patients Significantly Reduces Hospitalizations and Improves Survival
Breakthrough findings from study led by Mount Sinai researcher could improve outcomes for high-risk patients
Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children
Mount Sinai Health System and Memorial Sloan Kettering Cancer Center researchers have developed a new drug delivery approach that uses nanoparticles to enable more effective and targeted delivery of anti-cancer drugs to treat brain tumors in children.
Mount Sinai Experts Elected as Fellows of the American Academy of Microbiology
The American Academy of Microbiology has elected Florian Krammer, PhD, Mount Sinai Professor in Vaccinology, and Gustavo Palacios, PhD, Professor of Microbiology at the Icahn School of Medicine at Mount Sinai, along with 63 peers to its Class of 2023 fellows. Fellows of the American Academy of Microbiology, an honorary leadership group and a think tank within the American Society for Microbiology (ASM), are elected annually through a highly selective peer-review process based on their records of scientific achievement and original contributions that have advanced microbiology.
First Stem Cells From a Bat Species Known to Harbor SARS-CoV-2 Could Shed Light on Virus Survival and Molecular Adaptability
Researchers from the Icahn School of Medicine at Mount Sinai have generated the first induced pluripotent stem cells (iPSCs) from bats, gaining valuable insights into the close relationship between bats and viruses.
Immunotherapy After Surgery Provides Significant, Durable Benefit for High-Risk Bladder Patients
Immunotherapy after surgery increased bladder cancer patients’ chance of staying cancer-free compared to patients who received a placebo, according to clinical trial results shared in a late-breaking oral presentation at the American Society of Clinical Oncology (ASCO) 2023 Genitourinary Cancers Symposium in February.
Mount Sinai’s Arnhold Institute for Global Health Awarded $8 Million to Expand Global Partnerships in Education and Research
The Arnhold Institute for Global Health at Mount Sinai has received $8 million from the Arnhold Foundation, enabling doctors, researchers, and students to advance its already-strong base of clinical education programs, training, research, and care services to address the world’s leading health issues and improve global health systems.
Cocaine Use Disorder Alters Gene Networks of Neuroinflammation and Neurotransmission in Humans
Analysis reveals similar changes in the brain’s functioning in both humans and mouse models
Mount Sinai Researchers Identify Functions of Muscle Surrounding Hair Follicles That Cause Hair Regression
MEDIA ADVISORY UNDER EMBARGO UNTIL 11:00AM ET, MONDAY, JANUARY 30, 2023 Paper Title: Progenitor-derived endothelin controls dermal sheath contraction for hair follicle regression Journal: Nature Cell Biology (January 30, 2023) Authors: Michael Rendl, MD, Professor of Cell, Developmental and Regenerative Biology,…
Learn CPR and Lower Your Stress: Mount Sinai Cardiologists Emphasize Their Importance During American Heart Month
Doctors warn about lack of knowledge of administering CPR, especially in high-risk groups, and the rise of stress-related heart issues
Valentin Fuster, MD, PhD, Receives Prestigious Award from City of Barcelona, Spain
Mount Sinai Heart President given top honor for his extraordinary scientific achievements
Mount Sinai Researchers First to Identify That Two Separate Eye Diseases May Contribute to Common Blinding Eye Condition
Two separate eye diseases may contribute to age-related macular degeneration (AMD), a leading cause of blindness in the United States, according to a new study from New York Eye and Ear Infirmary of Mount Sinai.
Researchers Leverage Pathogen “Fingerprints” in Blood to Accelerate Infection Diagnosis
MEDIA ADVISORY UNDER EMBARGO UNTIL DECEMBER 21, 2022 in Cell Systems Corresponding Authors: Elena Zaslavsky, PhD, Associate Professor of Neurology, Icahn School of Medicine at Mount Sinai; Steven H. Kleinstein, PhD, Anthony Brady Professor of Pathology at Yale School of…
Mount Sinai’s Dubin Breast Cancer Center Raises $3 Million for 12th Anniversary
The Dubin Breast Center of The Tisch Cancer Institute at the Mount Sinai Health System celebrated its 12th anniversary with its annual gala on Monday, December 12.
Mount Sinai Study Links Molecular Changes to Long COVID a Year After Hospitalization
Study is one of the first to associate long COVID symptoms with changes in gene expression during acute COVID-19
Mount Sinai First in Region Offering Telehealth Visits for Low-Acuity 911 Ambulance Calls
Unique program keeps patients with less severe conditions out of the Emergency Department, saving them time and money
Mount Sinai Study Uncovers Inflammatory Markers that May Predict a Response in Certain Patients to COVID-19 Immunotherapies
Researchers at The Tisch Cancer Institute uncovered inflammatory markers that may predict which COVID-19 patients are more likely to respond to therapies like the anti-cancer drug pacritinib, according to phase 2 trial results published in JAMA Network Open in December.
Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease
Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces the publication of new real-world evidence (RWE) in Primary Care and Community Health demonstrating the Company’s KidneyIntelX bioprognostic™ test resulted in changed clinical decision making for patients in the early-stage of diabetic kidney disease (DKD) being cared for within the Mount Sinai Health System’s Population Health Ambulatory Pharmacy and Condition Management programs.
Mount Sinai Scientists Awarded Grant from Chan Zuckerberg Initiative to Advance Understanding and Therapeutics for Rare Blood Vessel Disease
Physician-scientist Fanny Elahi, MD, PhD, to lead research team in collaboration with non-profit organization
Unraveling Cancer’s Complexities
Mount Sinai physician-scientists share insights and report on developments in the field in “Frontiers of Medical Research: Cancer”
Researchers Identify the Role of an Alzheimer’s Disease Risk Gene in the Brain
Inflammatory response linked to amyloid plaque buildup
Samin Sharma, MD, Named Director of the Mount Sinai Cardiovascular Clinical Institute
Mount Sinai Heart expands leadership
Lung Cancer Screening Dramatically Increases Long-term Survival Rate
Diagnosing early-stage lung cancer with low-dose computed tomography (CT) screening drastically improves the survival rate of cancer patients over a 20-year period, according to a large-scale international study being presented by Mount Sinai researchers at the annual meeting of the Radiological Society of North America.
The Polycystic Kidney Disease (PKD) Foundation Names Mount Sinai Health System Partner Clinic
The polycystic kidney disease (PKD) Foundation—the only organization in the U.S. dedicated solely to finding treatments and a cure for PKD recently named Mount Sinai Health System as a PKDF Partner Clinic for their desire to support patients with Autosomal Dominant PKD (ADPKD).
Mount Sinai Appoints Michal A. Elovitz, MD, as Dean for Women’s Health
Renowned preterm birth expert to lead efforts to improve women’s health and educate and empower women researchers